INS and type 2 diabetes mellitus: Decreased spliced XBP1 expression was observed in islets of type 2 diabetic patients [29] and studies adopting embryonic deletion of Xbp1 using the rat insulin promoter showed that it is required for optimal beta cell development and proinsulin processing [21].